Orano Med and RadioMedix announce dosing of first patients in AlphaMedix™ Phase 1 clinical trial
February 20, 2018 10:09 ET
|
Orano Med
COURBEVOIE, France and HOUSTON, Feb. 20, 2018 (GLOBE NEWSWIRE) -- Orano Med (formerly AREVA Med) and RadioMedix announced today the dosing of the first three patients in the AlphaMedix™ Phase 1...
アレバ･メド、新しい鉛212生産施設を開設
April 14, 2016 09:18 ET
|
AREVA Med
テキサス州プレイノ発 , April 14, 2016 (GLOBE NEWSWIRE) -- アレバ･メド (AREVA Med) は、米国テキサス州プレイノにある第2の高精度鉛212 (212Pb) 生産施設の運営を開始した。この施設はDDPU (国内ディストリビューション･精製ユニット)...
AREVA Med Inaugurates Second Lead-212 Production Facility
April 13, 2016 15:22 ET
|
AREVA Med
PLANO, Texas, April 13, 2016 (GLOBE NEWSWIRE) -- AREVA Med has launched operations at its second high-purity lead-212 (212Pb) production facility located in Plano, Texas. Known as the DDPU (Domestic...
Morphotek and AREVA Med to collaborate on Lead-212 Targeted Alpha Therapies
March 31, 2016 12:00 ET
|
AREVA Med
EXTON, Pa. and COURBEVOIE, France, March 31, 2016 (GLOBE NEWSWIRE) -- Morphotek®, Inc., a subsidiary of Eisai Inc., and AREVA Med, the AREVA Group medical subsidiary developing innovative therapies...
AREVA Med Partners With Art Institute of Dallas (U.S.) and École Supérieure de Design Troyes (France)
February 29, 2016 13:30 ET
|
AREVA Med
PLANO, Texas, Feb. 29, 2016 (GLOBE NEWSWIRE) -- AREVA Med, with roots in France and the U.S., has selected two top design schools – French École Supérieure de Design Troyes and U.S. Art Institute...
AREVA Med’s Second Production Facility on Schedule to Open in 2nd Quarter of 2016
January 21, 2016 12:48 ET
|
AREVA Med
PLANO, Texas, Jan. 21, 2016 (GLOBE NEWSWIRE) -- AREVA Med’s second high-purity lead-212 (212Pb) production facility is now well advanced in the construction and is expected to be operational, as...
AREVA Med Launches Construction in the U.S. of Second Facility to Produce Lead-212 Used for Developing Cancer Treatments
September 10, 2015 13:05 ET
|
AREVA Med
PLANO, Texas, Sept. 10, 2015 (GLOBE NEWSWIRE) -- AREVA Med has begun construction of the company's second lead-212 production facility, known as DDPU (Domestic Distribution and Purification Unit),...
AREVA Med and RadioMedix Partner to Develop New Treatment Against Neuroendocrine Tumors
May 18, 2015 09:00 ET
|
AREVA Med
HOUSTON and BETHESDA, Md., May 18, 2015 (GLOBE NEWSWIRE) -- RadioMedix, a clinical phase biotechnology company focused in the development of radiopharmaceuticals for targeted diagnosis and therapy of...
AREVA Med to Expand Production Capacities in the U.S.
November 03, 2014 08:00 ET
|
AREVA Med
BETHESDA, Md., Nov. 3, 2014 (GLOBE NEWSWIRE) -- AREVA Med announced today plans to build a new production facility in the United States. The company has acquired land in Plano, Texas, for the future...
AREVA Med Phase 1 Clinical Trial Expanded in U.S.
April 01, 2014 09:52 ET
|
AREVA Med
BETHESDA, Md., April 1, 2014 (GLOBE NEWSWIRE) -- AREVA Med announced today the expansion of its Phase 1 clinical trial through collaboration with University of California San Diego Moores Cancer...